Viewing Study NCT00201669


Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2025-12-25 @ 8:21 PM
Study NCT ID: NCT00201669
Status: COMPLETED
Last Update Posted: 2017-12-06
First Post: 2005-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma
Sponsor: Ohio State University Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module